SG Americas Securities, LLC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$320
+19.0%
58,720
+46.6%
0.00%
+100.0%
Q2 2023$269
-60.4%
40,062
-47.9%
0.00%
-75.0%
Q1 2023$679
+207.2%
76,854
+165.4%
0.01%
+166.7%
Q4 2022$221
-99.9%
28,962
+22.6%
0.00%
+50.0%
Q3 2022$168,000
-59.0%
23,623
-53.4%
0.00%
-50.0%
Q2 2022$410,000
+17.1%
50,678
+100.8%
0.00%
+33.3%
Q1 2022$350,000
-47.8%
25,239
+5.7%
0.00%
-25.0%
Q4 2021$670,000
+85.6%
23,876
+124.9%
0.00%
+100.0%
Q3 2021$361,000
+15.7%
10,614
+38.8%
0.00%
+100.0%
Q2 2021$312,000
-70.5%
7,645
-70.9%
0.00%
-83.3%
Q1 2021$1,059,000
+789.9%
26,301
+1203.3%
0.01%
+500.0%
Q4 2020$119,000
-77.7%
2,018
-81.6%
0.00%
-66.7%
Q3 2020$534,000
+173.8%
10,982
+68.4%
0.00%
+50.0%
Q4 2019$195,000
-73.1%
6,520
-56.5%
0.00%
-60.0%
Q2 2019$724,00015,0000.01%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q1 2022
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders